Abstract:Microcystins (MCs) are secondary metabolites generated by cyanobacterial blooms, among which microcystin-LR (MC-LR) stands out as the most widely distributed variant in aquatic environments. However, the effects of MC-LR on the colorectum and its role in promoting colorectal tumor progression remain unclear. Therefore, this study aims to scrutinize the impact of MC-LR on a mice model of colitis-associated colorectal cancer and elucidate the potential underlying molecular mechanisms. In this study, we used AOM/DSS mice and orally administered MC-LR at doses of 40 µg/kg or 200 µg/kg. Exposure to MC-LR increased tumor burden, promoted tumor growth, shortened colon size, and decreased goblet cell numbers and tight junction protein levels in intestinal tissues. Additionally, exposure to MC-LR induced alterations in the structure of gut microbiota in the mouse colon, characterized by an increase in the relative abundance of Escherichia_coli and Shigella_sonnei, and a decline in the relative abundance of Akkermansia_muciniphila. Transcriptomic analysis revealed that MC-LR exposure activated the IL-17 signaling pathway in mouse colorectal tissues and participated in inflammation regulation and immune response. Immunofluorescence results demonstrated an increase in T-helper 17 (Th17) cell levels in mouse colorectal tumors following MC-LR exposure. The results from RT-qPCR revealed that MC-LR induced the upregulation of IL-6, IL-1β, IL-10, IL-17A, TNF-α, CXCL1, CXCL2, CXCL5 and CCL20. The novelty of this study lies in its comprehensive approach to understanding the mechanisms by which MC-LR may contribute to CRC progression, offering new perspectives and valuable reference points for establishing guidance standards regarding MC-LR in drinking water. Our findings suggest that even at guideline value, MC-LR can have profound effects on susceptible mice, emphasizing the need for a reevaluation of guideline value and a deeper understanding of the role of environmental toxins in cancer progression.

Effects of microcystin-LR on bacterial and fungal functional genes profile in rat gut.

Effects of microcystin-LR on gut microflora in different gut regions of mice

A proteomic study on gastric impairment in rats caused by microcystin-LR

Comprehensive Insights into Microcystin-Lr Effects on Hepatic Lipid Metabolism Using Cross-Omics Technologies.

Systemic inflammatory response to daily exposure to microcystin-LR and the underlying gut microbial mechanisms

Long-Term Environmental Levels of Microcystin-LR Exposure Induces Colorectal Chronic Inflammation, Fibrosis and Barrier Disruption Via CSF1R/Rap1b Signaling Pathway

Effect of Microcystin-LR on Glucose and Lipid Metabolism in Mice

Microcystin-LR exposure interfered maintenance of colonic microenvironmental homeostasis in rat

Exposure to Microcystin-LR Promotes Colorectal Cancer Progression by Altering Gut Microbiota and Associated Metabolites in APCmin/+ Mice

Prior exposure to microcystin alters host gut resistome and is associated with dysregulated immune homeostasis in translatable mouse models

Revealing microcystin-LR ecotoxicity to earthworm (Eisenia fetida) at the intestinal cell level

Effects of Microcystin-Lr on Patterns of Inos and Cytokine Mrna Expression in Macrophages in Vitro.

Microcystin-leucine arginine exposure induced intestinal lipid accumulation and MC-LR efflux disorder in Lithobates catesbeianus tadpoles

The Differential Effects of Microcystin-Lr on Mitochondrial DNA in the Hippocampus and Cerebral Cortex.

Integration of metagenomic and metabolomic insights into the effects of microcystin-LR on intestinal microbiota of Litopenaeus vannamei

Effects of gut microflora on hepatic damage after acute liver injury in rats.

The cytotoxicity of microcystin-LR: ultrastructural and functional damage of cells

Toxicogenomic Evaluation Of Microcystin-Lr Treated With Ultrasonic Irradiation

Toxicity of three microcystin variants on the histology, physiological and metabolism of hepatopancreas and intestinal microbiota of Litopenaeus vannamei

The apoptotic effect of oral administration of microcystin-RR on mice liver.

Exposure to microcystin-LR promotes the progression of colitis-associated colorectal cancer by inducing barrier disruption and gut microbiota dysbiosis